(Circulation. 2001;104:310.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Division of Pediatric Cardiology (S.E.L.), University of Rochester Medical Center and Childrens Hospital at Strong, and Department of Pediatrics (S.E.L.), University of Rochester School of Medicine and Dentistry, Rochester, NY; the Department of Cardiology (S.E.L., S.D.C.), Childrens Hospital, and Department of Pediatrics, Harvard Medical School (S.E.L., S.D.C.), Boston, Mass; Department of Pediatrics, Boston Medical Center and Boston University School of Medicine, Boston, Mass (S.E.L.); Department of Biostatistics and Epidemiology (K.A.E., M.D.S.) and Department of Pediatrics, Division of Pediatric Cardiology (D.S.M.), Cleveland Clinic Foundation, Cleveland, Ohio; Department of Medicine, Brigham and Womans Hospital, Boston, Mass (E.J.O.); Department of Pediatrics, Division of Pediatric Cardiology, University of California, Los Angeles Medical Center and School of Medicine, Los Angeles (S.K.); Department of Pediatrics, Division of Pediatric Cardiology, Mt Sinai School of Medicine, New York, NY (W.W.L.); Department of Pediatrics, Division of Pediatric Cardiology, Presbyterian Hospital/Columbia University College of Physicians and Surgeons, New York, NY (T.J.S.); Department of Pediatrics, Division of Pediatric Cardiology, Baylor College of Medicine, Houston, Tex (J.T.B.); and the National Heart, Lung, and Blood Institute, Bethesda, Md (G.S.).
Correspondence to Dr S.E. Lipshultz, Division of Pediatric Cardiology, University of Rochester Medical Center and Childrens Hospital at Strong, 601 Elmwood Ave, Box 631, Rochester, NY 14642. E-mail steve_lipshultz{at}urmc.rochester.edu
Background To assess the reliability of pediatric echocardiographic measurements, we compared local measurements with those made at a central facility.
Methods and Results The comparison was based on the first echocardiographic recording obtained on 735 children of HIV-infected mothers at 10 clinical sites focusing on measurements of left ventricular (LV) dimension, wall thicknesses, and fractional shortening. The recordings were measured locally and then remeasured at a central facility. The highest agreement expressed as an intraclass correlation coefficient (ICC=0.97) was noted for LV dimension, with much lower agreement for posterior wall thickness (ICC=0.65), fractional shortening (ICC=0.64), and septal wall thickness (ICC=0.50). The mean dimension was 0.03 cm smaller in central measurements (95% prediction interval [PI], -0.32 to 0.25 cm) for which 95% PI reflects the magnitude of differences between local and central measurements. Mean posterior wall thickness was 0.02 cm larger in central measurements (95% PI, -0.18 to 0.22 cm). Mean fractional shortening was 1% smaller in central measurements. However, the 95% PI was -10% to 8%, indicating that a fractional shortening of 32% measured centrally could be anywhere between 22% and 40% when measured locally. Central measurements of mean septal thickness were
0.1 cm thicker than local ones (95% PI, -0.18 to 0.34 cm). Centrally measured wall thickness was more closely related to mortality and possibly was more valid than local measurements.
Conclusions Although LV dimension was reliably measured, local measurements of LV wall thickness and fractional shortening differed from central measurements.
Key Words: echocardiography pediatrics AIDS
This article has been cited by other articles:
![]() |
B. J. Foster, A. S. Mackie, M. Mitsnefes, H. Ali, S. Mamber, and S. D. Colan A Novel Method of Expressing Left Ventricular Mass Relative to Body Size in Children Circulation, May 27, 2008; 117(21): 2769 - 2775. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Lipshultz and T. L. Miller Establishing norms for echocardiographic measurements of cardiovascular structures and function in children J Appl Physiol, August 1, 2005; 99(2): 386 - 388. [Full Text] [PDF] |
||||
![]() |
S. E. Lipshultz, S. A. Vlach, S. R. Lipsitz, S. E. Sallan, M. L. Schwartz, and S. D. Colan Cardiac Changes Associated With Growth Hormone Therapy Among Children Treated With Anthracyclines Pediatrics, June 1, 2005; 115(6): 1613 - 1622. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Lipshultz, S. R. Lipsitz, S. E. Sallan, V. M. Dalton, S. M. Mone, R. D. Gelber, and S. D. Colan Chronic Progressive Cardiac Dysfunction Years After Doxorubicin Therapy for Childhood Acute Lymphoblastic Leukemia J. Clin. Oncol., April 20, 2005; 23(12): 2629 - 2636. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Napolitano Transgenic models in cardiac arrhythmias: how close can we get to the bedside? Cardiovasc Res, February 1, 2004; 61(2): 206 - 207. [Full Text] [PDF] |
||||
![]() |
S. E. Lipshultz, S. R. Lipsitz, S. E. Sallan, R. D. Gelber, and S. D. Colan In Reply: J. Clin. Oncol., September 1, 2003; 21(17): 3377 - 3378. [Full Text] [PDF] |
||||
![]() |
S. E. Lipshultz, S. R. Lipsitz, S. E. Sallan, V. C. Simbre II, S. L. Shaikh, S. M. Mone, R. D. Gelber, and S. D. Colan Long-Term Enalapril Therapy for Left Ventricular Dysfunction in Doxorubicin-Treated Survivors of Childhood Cancer J. Clin. Oncol., December 1, 2002; 20(23): 4517 - 4522. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |